Delivery Order SPE2DB22D1106-SPE2DB25FEJP3
Award Date
4/18/25
Potential Completion Date
4/21/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,549.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of April 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside was used for this award. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $21,627.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a completion date of February 4, 2025. The contract is a Firm Fixed Price Delivery Order, and there was no set-aside designation used. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,290.43 and is for the delivery of GEMTESA 75 MG TABLET 90S, a medical product. The contract is a firm fixed-price Delivery Order, with an ultimate completion date of July 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,493.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a final completion date of March 5, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $78,816.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of April 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was not designated as a Set-Aside contract. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $1,159.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a completion date of February 25, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds...
This federal contract award, valued at $2,677.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, a medical product, with a completion date of December 4, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,178.62 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $35,167.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of February 21, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $8,697.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of November 6, 2024. The contract is a Delivery Order and utilizes a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...